P21waf1/cip1 is down-regulated in conjunction with up-regulation of c-Fos in the lymphocytes of rheumatoid arthritis patients

被引:12
作者
Hikasa, M
Yamamoto, E
Kawasaki, H
Komai, K
Shiozawa, K
Hashiramoto, A
Miura, Y
Shiozawa, S [1 ]
机构
[1] Kobe Univ, Sch Med, Fac Hlth Sci, Dept Rheumatol, Kobe, Hyogo 6540142, Japan
[2] Konan Kakogawa Hosp, Dept Rheumatol, Kakogawa 6758545, Japan
[3] Kobe Univ Hosp, Div Rheumat Dis, Kobe, Hyogo 6500017, Japan
关键词
c-fos; rheumatoid arthritis; p21(waf1/cip1); STAT1; IFN gamma;
D O I
10.1016/S0006-291X(03)00574-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Features characteristic to rheumatoid arthritis (RA) including synovial overgrowth and joint destruction are experimentally produced by augmenting c-fos gene expression. We show that cyclin dependent kinase inhibitor p21(waf1/cip1),, that inhibits cell proliferation, is down-regulated in conjunction with up-regulation of c-fos in the lymphocytes of patients with RA. As to the mechanism of down-regulation of p21(waf1/cip1) gene expression, transfection studies in U937 cells showed that c-fos down-regulated phosphorylation and dimerization of signal transducers and activators of transcription (STAT) 1, thereby inhibiting interferon gamma-induced transactivation of p21(waf1/cip1). Phosphorylation of STAT1 was indeed decreased in the lymphocytes of patients with RA. Thus, under overexpression of c-fos gene, c-Fos inactivates STAT1 to down-regulate p21(waf1/cip1) gene expression in the lymphocytes of patients with RA, and in this way may enhance proliferation of lymphocytes. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:143 / 147
页数:5
相关论文
共 29 条
[1]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[2]   Direct evidence of high DNA binding activity of transcription factor AP-1 in rheumatoid arthritis synovium [J].
Asahara, H ;
Fujisawa, K ;
Kobata, T ;
Hasunuma, T ;
Maeda, T ;
Asanuma, M ;
Ogawa, N ;
Inoue, H ;
Sumida, T ;
Nishioka, K .
ARTHRITIS AND RHEUMATISM, 1997, 40 (05) :912-918
[3]   Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21(WAF1/CIP1) mediated by STAT1 [J].
Chin, YE ;
Kitagawa, M ;
Su, WCS ;
You, ZH ;
Iwamoto, Y ;
Fu, XY .
SCIENCE, 1996, 272 (5262) :719-722
[4]   STATs and gene regulation [J].
Darnell, JE .
SCIENCE, 1997, 277 (5332) :1630-1635
[5]  
El-Deiry WS, 1998, CURR TOP MICROBIOL, V227, P121
[6]  
ELDEIRY WS, 1995, CANCER RES, V55, P2910
[7]   IS PANNUS A RESIDUE OF INFLAMMATION [J].
FASSBENDER, HG .
ARTHRITIS AND RHEUMATISM, 1984, 27 (08) :956-957
[8]   Transcriptional regulation of the p21(WAF1/ClP1) gene [J].
Gartel, AL ;
Tyner, AL .
EXPERIMENTAL CELL RESEARCH, 1999, 246 (02) :280-289
[9]   A novel method for real time quantitative RT PCR [J].
Gibson, UEM ;
Heid, CA ;
Williams, PM .
GENOME RESEARCH, 1996, 6 (10) :995-1001
[10]   Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain [J].
Gu, W ;
Roeder, RG .
CELL, 1997, 90 (04) :595-606